Paul Suparna, Connor Judy, Nesspor Tom, Haytko Peter, Boakye Ken, Chiu Mark L, Jiang Haiyan
Biologics Research, Biotechnology Center of Excellence, Janssen Research and Development, LLC., 1400 McKean Road, Spring House, PA 19477, USA.
Biologics Research, Biotechnology Center of Excellence, Janssen Research and Development, LLC., 3210 Merryfield Row, San Diego, CA 92121, USA.
Protein Expr Purif. 2016 May;121:133-40. doi: 10.1016/j.pep.2016.01.014. Epub 2016 Jan 27.
Bispecific antibody generation is actively pursued for therapeutic and research antibody development. Although there are multiple strategies for generating bispecific antibodies (bsAbs); the common challenge is to develop a scalable method to prepare bsAbs with high purity and yield. The controlled Fab-arm exchange (cFAE) method combines two parental monoclonal antibodies (mAbs), each with a matched point mutation, F405L and K409R in the respective CH3 domains. The conventional process employs two steps: the purification of two parental mAbs from culture supernatants followed by cFAE. Following a reduction/oxidation reaction, the bispecific mAb is formed with greater than 95% heterodimerization efficiency. In this study, cFAE was initiated in culture supernatants expressing the two parental mAbs, thereby eliminating the need to first purify the parental mAbs. The bsAbs formed in culture supernatant was then purified using a Protein A affinity chromatography. The BsAbs generated in this manner had efficiency comparable to the conventional method using purified parental mAbs. BsAbs prepared by two different routes showed indistinguishable characteristics by SDS capillary electrophoresis, analytical size exclusion, and cation exchange chromatography. This alternative method significantly shortened timelines and reduced resources required for bsAb generation, providing an improved process with potential benefits in large-scale bsAb preparation, as well as for HTP small-scale bsAb matrix selection.
双特异性抗体的产生在治疗性和研究性抗体开发中受到积极关注。尽管有多种产生双特异性抗体(bsAbs)的策略,但常见的挑战是开发一种可扩展的方法来制备高纯度和高产量的bsAbs。可控Fab臂交换(cFAE)方法将两种亲本单克隆抗体(mAbs)结合在一起,每种抗体在各自的CH3结构域中都有匹配的点突变F405L和K409R。传统方法包括两个步骤:从培养上清液中纯化两种亲本mAb,然后进行cFAE。经过还原/氧化反应后,形成双特异性mAb,异源二聚化效率大于95%。在本研究中,cFAE在表达两种亲本mAb的培养上清液中启动,从而无需首先纯化亲本mAb。然后使用蛋白A亲和色谱法纯化培养上清液中形成的bsAbs。以这种方式产生的BsAbs的效率与使用纯化亲本mAb的传统方法相当。通过两种不同途径制备的BsAbs在SDS毛细管电泳、分析尺寸排阻和阳离子交换色谱中表现出难以区分的特征。这种替代方法显著缩短了时间线并减少了产生bsAb所需的资源,为大规模bsAb制备以及高通量小规模bsAb基质选择提供了一种具有潜在益处的改进方法。